INTACT INVESTMENT MANAGEMENT INC. - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 885 filers reported holding BAXTER INTL INC in Q3 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
INTACT INVESTMENT MANAGEMENT INC. ownership history of BAXTER INTL INC
ValueSharesWeighting
Q3 2023$434,010
-5.7%
11,500
+13.9%
0.02%0.0%
Q2 2023$460,15610,1000.02%
Q1 2023$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2022$147,813
-75.5%
2,900
-74.1%
0.01%
-70.0%
Q3 2022$604,000
-13.0%
11,200
+3.7%
0.02%
-9.1%
Q2 2022$694,000
-10.5%
10,800
+8.0%
0.02%
+10.0%
Q1 2022$775,000
+20.9%
10,000
+31.6%
0.02%
+5.3%
Q1 2021$641,000
+5.1%
7,6000.0%0.02%
-5.0%
Q4 2020$610,000
-0.2%
7,6000.0%0.02%
-4.8%
Q3 2020$611,000
+18.4%
7,600
+26.7%
0.02%
+10.5%
Q2 2020$516,000
-26.0%
6,000
-30.2%
0.02%
-36.7%
Q1 2020$697,000
-2.9%
8,6000.0%0.03%
+25.0%
Q4 2019$718,000
+217.7%
8,600
+145.7%
0.02%
+166.7%
Q4 2017$226,0000.0%3,500
-2.8%
0.01%
-10.0%
Q3 2017$226,000
-37.7%
3,600
-40.0%
0.01%
-37.5%
Q2 2017$363,000
-1.4%
6,000
-15.5%
0.02%
+6.7%
Q1 2017$368,000
+2.5%
7,100
-12.3%
0.02%
+15.4%
Q4 2016$359,000
-85.7%
8,100
-87.7%
0.01%
-88.4%
Q4 2015$2,505,000
+3.3%
65,700
-11.0%
0.11%
+3.7%
Q3 2015$2,424,000
-56.1%
73,800
-6.6%
0.11%
-52.6%
Q2 2015$5,521,000
+15.8%
79,000
+13.5%
0.23%
+18.8%
Q1 2015$4,766,000
-7.5%
69,600
-1.0%
0.19%
-6.3%
Q4 2014$5,152,000
+84.6%
70,300
+80.7%
0.20%
+78.3%
Q3 2014$2,791,000
+66.6%
38,900
+67.9%
0.12%
+69.1%
Q2 2014$1,675,000
-1.8%
23,1700.0%0.07%
-9.3%
Q1 2014$1,705,000
+250.1%
23,170
+231.0%
0.08%
+212.5%
Q4 2013$487,000
+37.2%
7,000
+29.6%
0.02%
+26.3%
Q3 2013$355,0005,4000.02%
Other shareholders
BAXTER INTL INC shareholders Q3 2023
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders